Phase II study of atezolizumab for pretreated advanced / recurrent non-small cell lung cancer with idiopathic interstitial pneumonia (TORG1936 / AMBITIOUS study)
Ikeda, S., Kato, T., Kenmotsu, H., Ogura, T., Iwasawa, S., Iwasawa, T., Kasajima, R., Miyagi, Y., Misumi, T., Yamanaka, T., Okamoto, H.Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz437.060
Date:
November, 2019
File:
PDF, 83 KB
2019